Ryan Crowe | executive |
Leonard Schleifer | executive |
George Yancopoulos | executive |
Marion McCourt | executive |
Christopher Fenimore | executive |
Tyler Van Buren | analyst |
Evan Seigerman | analyst |
Brian Abrahams | analyst |
Cory Kasimov | analyst |
Christopher Raymond | analyst |
Christopher Schott | analyst |
Timothy Anderson | analyst |
David Risinger | analyst |
Salveen Richter | analyst |
Carter L. Gould | analyst |
Mohit Bansal | analyst |
Welcome to the Regeneron Pharmaceuticals Second Quarter 2024 Earnings Conference Call. My name is Shannon, and I will be your operator for today's call. [Operator Instructions]. Please note that this conference call is being recorded.
I will now turn the call over to Ryan Crowe, Senior Vice President, Investor Relations.